We are live on ! Find out more
TOV

JLens 500 Jewish Advocacy U.S. ETF

12 hedge funds and large institutions have $32.4M invested in JLens 500 Jewish Advocacy U.S. ETF in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

363% more capital invested

Capital invested by funds: $7M → $32.4M (+$25.4M)

200% more funds holding

Funds holding: 412 (+8)

13.77% more ownership

Funds ownership: 5.88%19.64% (+14%)

Holders
12
Holders Change
+8
Holders Change %
+200%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

TOV Hedge Fund Activity: Q2 2025 in Review

12 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in JLens 500 Jewish Advocacy U.S. ETF (TOV) for Q2 2025, worth a combined $32.4M — up 363% from $7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TOV positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cambridge Associates, opening a new position worth an estimated $15.3M.

  • 12 institutional investors held JLens 500 Jewish Advocacy U.S. ETF (TOV) as of Q2 2025, up from 4 in Q1 2025.
  • Funds reported $32.4M of JLens 500 Jewish Advocacy U.S. ETF stock for Q2 2025, up 363% quarter-over-quarter.
  • 9 funds opened new JLens 500 Jewish Advocacy U.S. ETF positions in Q2 2025 and 0 closed out, a net change of +9 holders.
  • The largest JLens 500 Jewish Advocacy U.S. ETF buyer in Q2 2025 was Cambridge Associates, an estimated $15.3M added.

Based on aggregated 13F filings for Q2 2025.